Saturday, 27 February 2016

FDA wants your opinion on the Return of Genetic Test Results

Here's your chance to chime in possibly make a change or create standards on how genetic test results are returned. 

The Food and Drug Administration (FDA) is announcing the following public workshop titled “Patient and Medical Professional Perspectives on the Return of Genetic Test Results.” The purpose of this workshop is to understand patient and provider perspectives on receiving genetic test results. The topic(s) to be discussed will focus on better defining the specific information patients and providers prefer to receive, how those results should be returned, and what information is needed to understand the results so that they may effectively aid in medical decision making.

Registrations is closed but 
You have two other ways to participate:
  1. Watch Webcast. The meeting will also be Webcast. Comments can be sent in the mail addressed to Division of Dockets Management (HFA-305), FDA, 5630 Fishers Lane, and Rm. 1061, Rockville, MD 20852.
  2. Submit comments online. Comments can also be submitted online by March 31st. All submissions, whether done through the mail or online must include reference to: “Docket No.  FDA-2015-N-4809 for `Patient and Medical Professional Perspectives on the Return of Genetic Test Results; Public Workshop; Request for Comments.’”


Friday, 26 February 2016

Amplication Free sequencing. Nanostring @ AGBT16

As mentioned by Keith, sequencing by hybridisation isn't a novel idea in fact i thought that was the technology that might speed up sequencing by orders of magnitude of n where n is the length of your oligos.
However, what's interesting about nanostring is that their tech uses no enzymes in the sequencing process.
It's still in early stages of development, shall keep my eyes peeled on them. Maybe they might grow big enough for a sequencing company to consider suing them as well.

Hope over to Omics! for a more extensive write-up

Datanami, Woe be me